MARTIN J GEPSMAN, a director at $CME, sold 300 shares of the company on 02-20-2026 for an estimated $91,770. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.2% of their shares of this class of stock. Following this trade, they now own 24,999 shares of this class of $CME stock.
$CME Insider Trading Activity
$CME insiders have traded $CME stock on the open market 16 times in the past 6 months. Of those trades, 4 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $6,738,815.
- SUNIL CUTINHO (Chief Information Officer) has made 0 purchases and 2 sales selling 11,896 shares for an estimated $3,229,444.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
- HAROLD EUGENE JR. FORD sold 1,000 shares for an estimated $263,530
- DENNIS SUSKIND sold 748 shares for an estimated $224,400
- JONATHAN L MARCUS (Sr MD General Counsel) has made 0 purchases and 2 sales selling 768 shares for an estimated $200,072.
- WILLIAM R SHEPARD has made 4 purchases buying 536 shares for an estimated $145,679 and 0 sales.
- TIMOTHY FRANCIS MCCOURT (Sr MD Global Head Equity & FX) sold 379 shares for an estimated $98,475
- MARTIN J GEPSMAN sold 300 shares for an estimated $91,770
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CME Hedge Fund Activity
We have seen 832 institutional investors add shares of $CME stock to their portfolio, and 802 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,716,211 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $2,107,142,899
- STRIVE ASSET MANAGEMENT, LLC added 2,355,701 shares (+inf%) to their portfolio in Q3 2025, for an estimated $636,486,853
- VICTORY CAPITAL MANAGEMENT INC added 1,807,491 shares (+746.4%) to their portfolio in Q4 2025, for an estimated $493,589,642
- JPMORGAN CHASE & CO added 1,559,916 shares (+16.3%) to their portfolio in Q4 2025, for an estimated $425,981,861
- LONGVIEW PARTNERS (GUERNSEY) LTD added 1,386,768 shares (+inf%) to their portfolio in Q4 2025, for an estimated $378,698,605
- LONDON & CAPITAL ASSET MANAGEMENT LTD added 1,267,709 shares (+662.1%) to their portfolio in Q4 2025, for an estimated $346,185,973
- AMERIPRISE FINANCIAL INC removed 1,098,237 shares (-22.8%) from their portfolio in Q4 2025, for an estimated $299,906,559
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CME Revenue
$CME had revenues of $1.6B in Q4 2025. This is an increase of 8.09% from the same period in the prior year.
You can track CME financials on Quiver Quantitative's CME stock page.
$CME Congressional Stock Trading
Members of Congress have traded $CME stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CME Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/13/2025
- Morgan Stanley issued a "Overweight" rating on 10/23/2025
- Deutsche Bank issued a "Buy" rating on 10/23/2025
- JP Morgan issued a "Underweight" rating on 09/25/2025
- Citigroup issued a "Buy" rating on 09/25/2025
To track analyst ratings and price targets for $CME, check out Quiver Quantitative's $CME forecast page.
$CME Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 11 analysts offer price targets for $CME in the last 6 months, with a median target of $307.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $312.0 on 02/05/2026
- Ashish Sabadra from RBC Capital set a target price of $302.0 on 02/05/2026
- Michael Cyprys from Morgan Stanley set a target price of $340.0 on 02/05/2026
- Kenneth Worthington from JP Morgan set a target price of $266.0 on 02/05/2026
- Bill Katz from TD Cowen set a target price of $328.0 on 02/05/2026
- Patrick Moley from Piper Sandler set a target price of $313.0 on 11/13/2025
- Brian Bedell from Deutsche Bank set a target price of $300.0 on 10/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
